Literature DB >> 7759109

Mapping of the HSD17B2 gene encoding type II 17 beta-hydroxysteroid dehydrogenase close to D16S422 on chromosome 16q24.1-q24.2.

F Durocher1, J Morissette, Y Labrie, F Labrie, J Simard.   

Abstract

The enzymes of the 17 beta-hydroxysteroid dehydrogenase (17 beta-HSD) gene family are responsible for a key step in the formation and degradation of androgens and estrogens: catalyzing the interconversion of 17-ketosteroids and their active 17 beta-hydroxysteroid counterparts. The structure of human type II 17 beta-HSD cDNA was recently reported. This enzyme catalyzes the interconversion of delta 4-androstenedione and testosterone, androstanedione and dihydrotestosterone, and estrone and 17 beta-estradiol, whereas type I 17 beta-HSD catalyzes exclusively the interconversion of estrogens. To locate the HSD17B2 gene, the novel dinucleotide CA repeat sequence found 571 bp downstream from the end of exon 1 was genotyped into eight CEPH reference families by PCR. Two-point linkage analysis was performed between the latter polymorphism and the 2066 microsatellite markers of Généthon. The maximal pairwise lod score (Zmax = 33.3) with a maximal recombination fraction (theta max) of 0.008 was obtained with the marker D16S422 located on 16q24.1-q24.2. To define further the localization of the HSD17B2 gene, we constructed a high-resolution genetic map of the region flanking the polymorphic HSD17B2 gene including eight Généthon markers. The order of the HSD17B2 gene and markers is qter-D16S516-D16S504-D16S507-D16S505-D16S511+ ++-[HSD17B2-D16S422]-D16S520- D16S413-tel.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7759109     DOI: 10.1016/0888-7543(95)80017-g

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  5 in total

1.  Allelic imbalance on 16q in small, unifocal hepatocellular carcinoma: correlation with HBV and HCV infections and cellular proliferation rate.

Authors:  L Gramantieri; D Trerè; A Pession; F Piscaglia; L Masi; S Gaiani; A Mazziotti; L Bolondi
Journal:  Dig Dis Sci       Date:  2000-02       Impact factor: 3.199

2.  Localization of a breast cancer tumour-suppressor gene to a 3-cM interval within chromosomal region 16q22.

Authors:  A Iida; R Isobe; M Yoshimoto; F Kasumi; Y Nakamura; M Emi
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

3.  Postmenopausal serum androstenedione levels are associated with the calcitonin receptor gene polymorphism T1377c. A pilot study.

Authors:  I Zofková; K Zajicková; M Hill
Journal:  J Endocrinol Invest       Date:  2004-05       Impact factor: 4.256

4.  Retinoic acid (RA) regulates 17beta-hydroxysteroid dehydrogenase type 2 expression in endometrium: interaction of RA receptors with specificity protein (SP) 1/SP3 for estradiol metabolism.

Authors:  You-Hong Cheng; Ping Yin; Qing Xue; Bertan Yilmaz; Marcia I Dawson; Serdar E Bulun
Journal:  J Clin Endocrinol Metab       Date:  2008-02-12       Impact factor: 5.958

5.  Three independently deleted regions at chromosome arm 16q in human prostate cancer: allelic loss at 16q24.1-q24.2 is associated with aggressive behaviour of the disease, recurrent growth, poor differentiation of the tumour and poor prognosis for the patient.

Authors:  J P Elo; P Härkönen; A P Kyllönen; O Lukkarinen; P Vihko
Journal:  Br J Cancer       Date:  1999-01       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.